Exercise training improves adipose tissue metabolism and vasculature regardless of baseline glucose tolerance and sex by Honkala, Sanna Maria et al.
BMJ Open Diab Res Care 2020;8:e000830. doi:10.1136/bmjdrc-2019-000830
Open access 
1
Exercise training improves adipose 
tissue metabolism and vasculature 
regardless of baseline glucose tolerance 
and sex
Sanna Maria Honkala,1 Piryanka Motiani,1 Riikka Kivelä,2 
Karthik Amudhala Hemanthakumar,2 Erik Tolvanen,2 Kumail Kumar Motiani,1 
Jari- Joonas Eskelinen,1 Kirsi A Virtanen,1 Jukka Kemppainen,1 
Marja Anneli Heiskanen,1 Eliisa Löyttyniemi,3 Pirjo Nuutila,1,4 Kari K Kalliokoski,1 
Jarna Christina Hannukainen   1
For numbered affiliations see 
end of article.
Correspondence to
Dr Jarna Christina 
Hannukainen;  
 jarna. hannukainen@ tyks. fi
To cite: Honkala SM, Motiani P, 
Kivelä R, et al. Exercise training 
improves adipose tissue 
metabolism and vasculature 
regardless of baseline 
glucose tolerance and sex. 
BMJ Open Diab Res Care 
2020;8:e000830. doi:10.1136/
bmjdrc-2019-000830
 ► Additional material is 
published online only. To view 
please visit the journal online 
(http:// dx. doi. org/ 10. 1136/ 
bmjdrc- 2019- 000830).
SMH and PM contributed 
equally.
This study has been previously 
presented at the ADA 77th 
Scientific Sessions (2017, 
USA) and European College of 
Sport Science Congress (2017, 
Germany).
Received 15 August 2019
Revised 8 May 2020
Accepted 10 June 2020
Original research
Metabolism
© Author(s) (or their 
employer(s)) 2020. Re- use 
permitted under CC BY- NC. No 
commercial re- use. See rights 
and permissions. Published 
by BMJ.
ABSTRACT
Introduction We investigated the effects of a supervised 
progressive sprint interval training (SIT) and moderate- 
intensity continuous training (MICT) on adipocyte morphology 
and adipose tissue metabolism and function; we also tested 
whether the responses were similar regardless of baseline 
glucose tolerance and sex.
Research design and methods 26 insulin- resistant (IR) and 
28 healthy participants were randomized into 2- week- long 
SIT (4–6×30 s at maximum effort) and MICT (40–60 min at 
60% of maximal aerobic capacity (VO2peak)). Insulin- stimulated 
glucose uptake and fasting- free fatty acid uptake in visceral 
adipose tissue (VAT), abdominal and femoral subcutaneous 
adipose tissues (SATs) were quantified with positron emission 
tomography. Abdominal SAT biopsies were collected to 
determine adipocyte morphology, gene expression markers 
of lipolysis, glucose and lipid metabolism and inflammation.
Results Training increased glucose uptake in VAT (p<0.001) 
and femoral SAT (p<0.001) and decreased fatty acid uptake 
in VAT (p=0.01) irrespective of baseline glucose tolerance 
and sex. In IR participants, training increased adipose 
tissue vasculature and decreased CD36 and ANGPTL4 gene 
expression in abdominal SAT. SIT was superior in increasing 
VO2peak and VAT glucose uptake in the IR group, whereas MICT 
reduced VAT fatty acid uptake more than SIT.
Conclusions Short- term training improves adipose tissue 
metabolism both in healthy and IR participants independently 
of the sex. Adipose tissue angiogenesis and gene expression 
was only significantly affected in IR participants.
INTRODUCTION
White adipose tissue has long been recog-
nized as the main site for the storage of excess 
energy delivered from food. Adipose tissue 
is also an endocrine organ, which regulates 
glucose and lipid metabolism and secretes a 
large number of hormones and cytokines.1 
In obesity and insulin resistance (IR), the 
metabolism of adipose tissue deteriorates and 
this is indicated by adipocyte hypertrophy 
and hyperplasia, macrophage infiltration, 
impaired insulin signaling and IR.1 2 Impaired 
adipose tissue metabolism leads to the 
release of inflammatory adipokines and large 
Significance of this study
What is already known about this subject?
 ► Adipose tissue metabolism and vasculature is im-
paired and inflammation increased in type 2 diabetes 
and obesity. Exercise training has beneficial effects 
on adipose tissue, but little is known about the effect 
on glucose and free fatty acid (FFA) metabolism.
What are the new findings?
 ► Already short- term training improves adipose tis-
sue glucose and fatty acid metabolism especially 
in visceral adipose tissue despite the baseline glu-
cose tolerance and sex. This study proposes that SIT 
improves visceral adipose tissue insulin- stimulated 
glucose uptake more efficiently than MICT, whereas 
MICT is preferable for visceral adipose tissue FFA 
uptake.
 ► After 2 weeks of exercise training, improvements 
could already be seen in glucose and fatty acid me-
tabolism especially in visceral adipose tissue despite 
the baseline glucose tolerance and sex.
 ► This study proposes that sprint interval training (SIT) 
improves visceral adipose tissue insulin- stimulated 
glucose uptake more efficiently than moderate- 
intensity continuous training (MICT), whereas MICT 
is preferable for improvements in visceral adipose 
tissue FFA uptake.
 ► Training decreases adipose tissue FFA uptake and 
the expression of FATB4, CD36 and ANGPTL4 mRNA 
and increases adipose tissue vascularization in 
insulin- resistant participants.
How might these results change the focus of 
research or clinical practice?
 ► Connections between adipose tissue and other or-
gans should be studied in more detail. This study 
also strengthens the potential of exercise training in 
the prevention of type 2 diabetes.
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amounts of free fatty acids (FFAs) resulting in the accu-
mulation of ectopic fat and lipotoxicity in non- adipose 
tissues, such as muscle, liver and pancreas.1 3
Previous animal and human studies have shown that 
regular exercise training has beneficial effects on adipose 
tissue. Regular exercise training has been shown, both in 
subcutaneous adipose tissue (SAT) and visceral adipose 
tissue (VAT), to reduce adipose tissue mass,4 5 adipocyte 
hypertrophy, adipose tissue inflammation6 and increase 
mitochondrial function and biogenesis7 in humans and 
rodents. A recent study showed that exercise training 
influences (increase/decrease) global expression of 
inflammation- related factors especially in abdominal SAT 
especially in dysglycemic men.6 Emerging evidence from 
preclinical studies suggest that training- induced effects 
on adipose tissues are tissue specific.8–10 For example, 
VAT has shown to be more responsive to exercise training 
due to its higher level of adrenergic activation.7 In addi-
tion, our previous clinical studies using positron emission 
tomography (PET) have shown that VAT is metabolically 
more active than SAT with both a higher glucose uptake11 
and fatty acid uptake.12 However, studies comparing exer-
cise training- driven adaptions to SAT and VAT metabo-
lism in humans are more limited.
It is well known that exercise training leads to a decrease 
in plasma insulin levels and circulating catecholamines and 
seems to lead to increase in lipolysis in relation to exercise 
intensity.7 13 14 However, during high- intensity training, it has 
been suggested that the reduction in adipose tissue blood 
flow leads to a decrease in adipose tissue FFA release.15 
Sprint interval training (SIT) has been the focus of research 
as a time- saving training method and it has been suggested 
to be superior compared with moderate- intensity contin-
uous training (MICT) in improving whole- body glucose 
metabolism and maximal aerobic capacity (VO2peak).
16 17 
To our knowledge, no previous studies have investigated 
whether SIT or MICT is preferable in improving the depot- 
specific adipose tissue metabolism in insulin- resistant (IR) 
participants.
The aim of the present study was to investigate the 
effects of 2 weeks of supervised, progressive exercise 
training on VAT and SAT glucose as well as fatty acid 
metabolism in healthy participants and participants with 
IR. Furthermore, using abdominal SAT biopsies, we were 
able to determine the training- induced effects on adipo-
cyte cell size, adipose tissue vascularization and adipose 
tissue gene expression markers related to lipolysis, inflam-
mation, adipogenesis, and glucose and FFA transport. 
Currently it is unclear whether the training responses 
on adipose tissue metabolism are similar between 
healthy and IR participants, and whether SIT is supe-
rior to MICT.18 19 The outcome data were also compared 
between IR men and women as previous studies have 
shown sex differences in adipose tissue metabolism.20 
Thus, the present study examined in middle- aged, seden-
tary participants whether training responses are similar 
in different adipose tissues:
1. Between healthy and IR participants?
2. After SIT compared with MICT in IR participants?
3. Between women and men in IR participants?
We hypothesized that already 2 weeks of exercise 
training would induce beneficial changes in adipose 
tissue glucose and fatty acid metabolism both in healthy 
and IR participants and these changes would be asso-
ciated with reduced adipocyte cell size and improved 
gene expression profile. We also hypothesized that these 
improvements would be seen both after SIT and MICT 
regardless of the sex.
RESEARCH DESIGN AND METHODS
Ethics
The study was part of a larger clinical trial (NCT01344928) 
entitled “The effects of short- term high- intensity interval 
training on tissue glucose and fat metabolism in healthy 
participants and in patients with type 2 diabetes.” The 
primary objective of the larger trial was to study the effects 
of exercise training on skeletal muscle and the outcomes 
of the present study are explorative. The results related 
to whole- body insulin sensitivity (M- value), aerobic 
fitness and basic characteristics in this manuscript have 
already been published.21–24 The main parameters of the 
present study, adipose tissue metabolism, cell size and 
gene expression have not been published before either 
in healthy or in IR subjects. The study was performed at 
the Turku PET Centre, University of Turku and Turku 
University Hospital (Turku, Finland) and the Paavo 
Nurmi Centre (Turku, Finland) between March 2011 
and September 2015.
Participants
Middle- aged, physically inactive, healthy men partic-
ipants (n=28) and woman and men participants with 
IR (n=26) were recruited for the study via newspaper 
advertisements, personal contacts, and electronic and 
traditional bulletin boards. The inclusion criteria for 
the healthy participants were men sex, age 40–55 years, 
body mass index (BMI) 18.5–30 kg/m2, VO2peak <40 mL/
kg/min and normal glycemic control.25 The allowed 
physical activity was limited to twice a week or less. A 
candidate was excluded if he or she had a condition 
which could potentially endanger their health during 
the study or interfere with the interpretation of the 
results as previously explained in detail.21 26 27 For the 
IR participants, the inclusion criteria were the same as 
for the healthy participants except for BMI 18.5–35 kg/
m2 and an impaired glucose tolerance (IGT) according 
to the criteria of the American Diabetes Association 
(ADA),25 an glycated hemoglobin (HbA1c) of less than 
7.5% and no insulin treatment in the cases of type 2 
diabetes.
Based on the oral glucose tolerance tests (OGTTs), all 
26 subjects met the criteria of IR set by ADA25 and had an 
HbA1c less than 7.5%. At the time of screening, four partic-
ipants were newly diagnosed with type 2 diabetes and had 
no previous medication. For the other 11 participants 
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with type 2 diabetes, the median diabetes duration was 
4.2 years and they were treated by oral hypoglycemic 
agents (11 with metformin, 5 with sitagliptin and 1 with 
glimepiride). Antidiabetic medication was withheld for 
48 hours and the participants were asked to avoid any 
exhausting exercise 48 hours prior to the measurements. 
All participants were asked not to change their habitual 
dietary intake during the study period. There was a total 
of seven dropouts in the study (figure 1).
Study design
The physical examination, OGTT, VO2max test, MRI, 
hyperinsulinemic clamp and PET with 14(R,S)-[18F]
fluoro-6- thia- heptadecanoic acid (FTHA) and 2-[18F]
fluoro-2- deoxy- D- glucose (FDG) tracers were performed 
before and after the training intervention as described 
in figure 2. Randomization either into the SIT or MICT 
group was done using a 1:1 allocation ratio and was 
performed separately for the healthy and prediabetic or 
type 2 diabetic participants with random permuted blocks, 
and this has been previously described in detail.21 26 28 
Power calculations were calculated based on the main 
outcomes of the whole trial (muscle glucose uptake) 
and have been described previously.22 29 No sample size 
calculation were specifically performed on the outcome 
measurements of the present study.
Exercise intervention
Participants participated in a 2- week supervised, progres-
sive training intervention, which included six training 
sessions of either SIT or MICT. The duration of the inter-
vention was based on previous studies showing improve-
ments in aerobic fitness and insulin sensitivity after only 
six training sessions.16 17 Each session was performed in 
laboratory conditions at the Turku PET Centre under the 
supervision of a member of the study group.
Each MICT session consisted of 40–60 min of cycling at 
a moderate intensity, which was determined as 60% of the 
measured VO2peak workload monitored by corresponding 
heart rate (Tunturi E85; Tunturi Fitness, Almere, The 
Netherlands) based on previous MICT protocols. The 
duration of the MICT increased progressively starting 
with 40 min and increasing by 10 min every other session 
up to 60 min. SIT sessions consisted of 4–6×30 s of all- 
out cycling bouts (Monark Ergomedic 894E; MONARK, 
Vansbro, Sweden), with a 4 min recovery between each 
bout. The number of bouts increased progressively 
Figure 1 Participant flow diagram. The analyses were carried out using the intention- to- treat principle and hence included all 
the randomized participants. MICT, moderate- intensity continuous training; SIT, sprint interval training; T2DM, type 2 diabetes 
mellitus.
Figure 2 The study design. [18F] FDG, 2-[18F]fluoro-2- deoxy- D- glucose; [18F] FTHA, 14(R,S)-[18F]fluoro-6- thia- 
heptadecanoic acid; FFA, free fatty acid; MICT, moderate- intensity continuous training; OGTT, oral glucose tolerance test; PET, 
positron emission tomography; SIT, sprint interval training; VO2max, maximal aerobic capacity.
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starting with four bouts and increasing by one every other 
session up to six bouts per session. The training load was 
individually determined (for healthy participants 7.5% of 
whole- body weight in kilogram, for IR participants 10% 
of lean body mass in kilogram).
Magnetic resonance imaging
VAT and abdominal SAT depot masses were measured 
with MRI (Philips Gyroscan Intera 1.5 T CV Nova Dual 
scanner, Philips Medical Systems). Whole- body (from 
head to knee) axial T1- weighted dual- fast field echo 
images (TE 2.3 and 4.7 ms, TR 120 ms, slice thickness 
10 mm without gap) were obtained and analyzed using 
sliceOmatic software V.4.3 (http://www. tomovision. 
com/ products/ sliceomatic. html). To obtain the tissue 
mass, the pixel surface area was multiplied by slice thick-
ness and density of adipose tissue 0.9196 kg/L. Unfortu-
nately, we were not able to measure femoral SAT mass as 
the MRI was not performed on the whole femoral region.
Positron emission tomography
Participants underwent four PET sessions: one [18F]
FTHA PET and one [18F]FDG PET before and after the 
training intervention. An euglycemic- hyperinsulinemic 
clamp was performed during [18F]FDG PET scanning 
day after a 10- hour fast based on the original protocol by 
Defronzo et al.30 During the first 4 min, a primed- constant 
insulin (Actrapid, 100 U/mL; Novo Nordisk, Bagsvaerd, 
Denmark) infusion was started at a rate of 120 mU/m2/
min of body surface area. After the first 4 min, the infu-
sion rate was decreased to 80 mU/m2/min for 3 min, and 
then further decreased to 40 mU/m2/min for the rest of 
the clamp. Normoglycemia was adjusted with 20% glucose 
infusion. Plasma glucose concentration was determined 
every 5–10 min from arterialized venous blood, and 
insulin and FFA concentrations were determined every 
30 and 60 min, respectively. The M- value was calculated 
from the glucose infusion rate and the measured glucose 
values collected when the participants had reached a 
steady state during the PET scan. The participants were 
positioned supine in a PET scanner (GE Discovery ST 
System, Milwaukee, Wisconsin, USA). To measure the 
plasma radioactivity for tracer input function, arterialized 
venous blood samples were collected repeatedly during 
[18F]FTHA and [18F]FDG scanning. Plasma radioactivity 
was measured with an automatic gamma counter (Wizard 
1480 3”; Wallac, Turku, Finland).
Regions of interest (ROIs)
All the imaging data were corrected for dead time, decay 
and measured photon attenuation, and then recon-
structed with scanner software using a 3D- ordered subset 
expectation maximization (3D- OSEM). Carimas 2.9 soft-
ware (Turku PET Centre, Turku, Finland) was used to 
analyze all the acquired PET- CT images. The ROIs were 
drawn manually on abdominal white SAT, on planes supe-
rior to the umbilicus, on VAT at the level of the umbilicus 
and on femoral subcutaneous tissue at the midregion of 
the thigh using the CT as an anatomical reference. The 
rate constant (Ki) for the uptake of radiotracer ([18F]
FTHA, [18F]FDG) into the cells was calculated using tissue 
time activity curves obtained from the abdominal SAT, 
VAT and femoral SAT using a fractional uptake method. 
Regional glucose and FFA uptakes were calculated by 
multiplying regional specific Ki by corresponding plasma 
glucose or FFA concentration, respectively. For glucose 
uptake the products were further divided by a lumped 
constant value of 1.0 and a tissue density of 0.9136 in 
adipose tissue.31
Adipose tissue biopsy and processing
Adipose tissue biopsies were performed under local anes-
thesia after all PET scannings had been performed. Abdom-
inal SAT was biopsied 6–8 cm laterally from the umbilicus 
under local anesthesia. For the gene expression analyses, 
the tissue sample was snap frozen in liquid nitrogen and 
stored at −70°C. For adipocyte cell size analyses tissue 
sample was fixed overnight in 4% paraformaldehyde (PFA) 
and embedded in paraffin for histological sections.
RNA isolation, complementary DNA (cDNA) synthesis and 
reverse transcriptase PCR
To isolate RNA from the human abdominal SAT, a piece of 
the tissue was homogenized in 700 µL of TRIsure reagent 
(Bioline, USA) using the bead- based tissue homoge-
nizer PowerLyzer24 (MO BIO Laboratories, USA). The 
genomic DNA (gDNA) in the lysate was removed using 
a gDNA eliminator spin column and the RNA was puri-
fied using RNeasy plus micro kit (Qiagen, no: 74034) 
according to the manufacturer’s instructions. RNA 
was reverse transcribed into cDNA with a high- capacity 
cDNA reverse transcription kit (Applied Biosystems, no: 
4368814), and gene expression was analyzed using a Fast-
Start Universal SYBR green master mix (Sigma- Aldrich, 
no: 04913914001) kit. The gene expression assay was 
performed in Bio- Rad C1000 thermal cycler according 
to the standardized protocol of the quantitative PCR 
master mix supplier. The quantification cycle (Cq) values 
of the technical triplicates were collected using Bio- Rad 
CFX Manager software (v3.1). The data were imported to 
qBase plus software (Biogazelle, https://www. qbaseplus. 
com), and the Cq average of each sample were normal-
ized to the housekeeping genes 36B4 and YWHAZ. The 
mRNA expression level was calculated and presented as 
fold a change (control=1). The human primer sequences 
are listed in online supplementary material.
Immunohistochemistry
Eight- micrometer- thick abdominal SAT sections were 
deparaffinized, incubated in high pH antigen retrieval 
buffer, rinsed with phosphate- buffered saline (PBS) and 
blocked with DIM buffer (5% normal donkey serum, 
0.2% bovine serum albumin, 0.3% Triton X-100% and 
0.005% sodium azide). The sections were incubated over-
night at 4°C with the following primary antibodies: mouse 
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anti- human CD31 (no: M0823; DAKO) and guinea pig 
anti- human perilipin (no: 20R- PP004; Fiztgerald) to 
stain vasculature and adipocytes, respectively. The Alexa- 
conjugated 488 and 594 secondary antibodies (Molecular 
Probes, Invitrogen) were used to detect primary antibody 
signal. The sections were stained for DAPI, rinsed with 
PBS, fixed with 1% PFA dissolved in PBS for 5 min at 
4°C. The stained sections were mounted using VECTA-
SHIELD Hardset Antifade Mounting Medium (H-1400; 
Vector Laboratories). Images of 40× were acquired using 
an Axio imager upright epifluorescence microscope (Carl 
Zeiss). The images were initially adjusted for threshold 
and area fraction tool was used to quantify the vascula-
ture area (%). The adipocyte size was measured using a 
cell profiler pipeline on a in Cell Profiler image analysis 
platform (Carpenter Lab, Broad Institute, https://www. 
cellprofiler. org).32
Biomarkers in plasma
Concentrations of tumor necrosis factor alpha (TNF-α), 
vascular endothelial growth factor D and A (VEGF- A) 
and also, C- reactive protein (CRP) were measured by 
multiplex bead assay analysis (Luminex Performance 
Assay Multiplex Kit; Procarta Immunoassay Affyme-
trix, Santa Clara, California, USA) according to the 
manufacturer’s instructions. Samples were analyzed 
with a LUMINEX 200 using Luminex xPonent software 
(Luminex, USA).
Other measurements
Aerobic capacity was determined with a VO2max cycling 
ergometer test (ergoline 800 s; VIASYS Healthcare, 
Germany) at the Paavo Nurmi Center (Turku, Finland) 
about 1 week before the first training session and 96 hours 
after the last training session. The VO2max test has previ-
ously been described in detail by Kiviniemi et al.33 Body 
composition was determined using the bioimped-
ance method (InBody 720; Mega Electronics, Kuopio, 
Finland).
Statistical analysis
The normal distribution of the variables was tested first 
with the Shapiro- Wilk test and evaluated visually. After 
the hierarchical mixed linear models, the normal distri-
bution of the studentized residuals was evaluated visu-
ally using Q- Q plots. Logarithmic (log10) or square root 
transformations were performed when appropriate to 
achieve a normal distribution. Statistical analyses were 
performed using hierarchical mixed linear models with 
compound symmetry covariance structure. First, the 
differences between healthy and IR men were studied with 
the model, which included one within- factor term (time, 
indicating the overall mean change between baseline and 
measurement after the intervention, used repeated state-
ment in SAS), one between- factor term (IR; healthy and 
IR men) and one interaction term (time×IR, indicating 
whether mean change during the study was different 
between healthy and IR men). IR women were completely 
excluded when comparing the effects of exercise in 
healthy and IR participants to avoid mixing the effects of 
sex and glucose intolerance. Second, in IR participants, 
differences between SIT and MICT, including both men 
and women, were studied using a model that included 
a within- factor time, a between- factor group (SIT and 
MICT) and interaction terms (time×training, whether the 
mean change was different in the SIT and MICT groups). 
Third, differences between men and women in IR partic-
ipants were studied using a model that included a within- 
factor group (men and women) and interaction terms 
(time × sex, whether mean change was different between 
men and women). Healthy subjects were excluded from 
the investigation of exercise regimen (SIT vs MICT) and 
sex, as we were specifically interested about whether the 
training responses are different after SIT and MICT in IR 
population known to have metabolic impairments. In all 
analyses, time, training, sex and insulin level (healthy vs 
IR) were handled as fixed effects.
The analyses were carried out using the intention- to- 
treat principle and included all the randomized partic-
ipants. Missing data points were accounted for by using 
a restricted maximum likelihood estimation within the 
linear mixed models. Correlations were calculated using 
Pearson’s correlation (Spearman’s rank correlation for 
non- normally distributed data). The statistical tests were 
performed as two sided and the level of statistical signifi-
cance was set at 0.05. The analyses were performed using 
an SAS System, V.9.4 for Windows (SAS Institute, Cary, 
North Carolina, USA).
RESULTS
Healthy versus insulin-resistant (IR) men
Of the 26 IR participants, 16 had type 2 diabetes and 
10 impaired fasting glucose and/or IGT. In the MICT 
group, all participants attended all training sessions 
and in the SIT group 21 participants (12 healthy, 9 IR) 
attended all six sessions and three participants (1 heathy, 
2 IR) attended five sessions. The total training time in 
the SIT group was on average 14±1.3 min as all partici-
pants were not able to perform all exercise bouts for the 
entire 30 s time. The average number of bouts for heathy 
was 27.5 and for IR 28.6 when the maximum number of 
bouts was 30 (4+4+5+5+6+6). The average power for the 
MICT group was 127.8±24.3 W (healthy 133.2±17.3 W 
and IR 117.7±32.6 W) and for the SIT group 427.3±62.3 
W (healthy 407.2±47.8 and IR 449.0±75.9 W) The drop-
outs are not included in these calculations.
The basic characteristics are presented as central 
tendencies in table 1 and as model- based means in 
table 2. The estimated mean differences, estimated mean 
ratios and upper and lower confidence intervals (Cls) 
for the variables are presented in the online supplemen-
tary tables 1 and 2. The IR men had significantly higher 
body adiposity, circulating lipid values, impaired glucose 
homeostasis and aerobic fitness as well as a tendency to 
have higher CRP levels compared with healthy controls 
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as summarized in table 2 and figure 3. Notably, the VAT 
and abdominal SAT masses were higher in IR men than 
in healthy men (38% and 36%, respectively). Both inter-
ventions were associated with reduced body adiposity and 
improved cholesterol values and aerobic fitness both in 
the healthy and the IR men (table 2) but did not have a 
significant effect on abdominal SAT adipocyte cell size 
(figure 4C).
At baseline, the IR men had significantly lower glucose 
uptake (µmol/min/100 g) in their VAT and in their 
femoral and abdominal SAT than the healthy men (all 
p<0.001; figure 5). These baseline differences were 
not seen when comparing the glucose uptake for each 
whole tissue mass in VAT and abdominal SAT (online 
supplementary figure 1). Glucose uptake in both VAT 
(time p<0.001; figure 5) and femoral SAT (time p<0.001; 
figure 5) increased with training, similarly in the healthy 
and IR men. Only femoral SAT glucose uptake remained 
lower in the IR men compared with the healthy partici-
pants after the intervention.
Before the intervention, the IR participants had lower 
visceral and abdominal SAT fatty acid uptake levels than 
the healthy men (both 35%, p<0.001; figure 6) but we 
found no difference in femoral SAT fatty acid uptake 
(p=0.3) between the groups. Both in healthy and IR men, 
training decreased fatty acid uptake in VAT (time p=0.01) 
and tended to decrease fatty acid uptake in abdominal 
and femoral SAT depots (time p=0.06 and time p=0.07, 
respectively). After training, the fatty acid uptake only 
remained lower in the abdominal SAT of the IR group 
when compared with the healthy men.
Of the plasma inflammation and vascularization 
markers studied, exercise training reduced TNF-α 
(p=0.02) and VEGF- A (p=0.02) in the whole group 
with no differences between healthy and IR men 
(figure 7). We did not observe baseline differences in 
adipose tissue mRNA expression in genes related to 
lipolysis, inflammation, adipogenesis and glucose and 
the FFA transport between IR and healthy participants 
(figure 7).
SIT versus MICT in IR men and women
No differences were observed in basic characteristics 
between the SIT and MICT training groups either at 
baseline or after the intervention (online supplementary 
table 3). For the whole group, training was associated 
with a decrease in VAT mass, high- density lipoprotein, 
low- density lipoprotein (LDL), total cholesterol, HbA1c 
concentrations and increase in whole- body insulin 
sensitivity without any significant differences being 
found between the two training modes. When studied 
Table 1 Central tendency and dispersion of the variables in each participant group at the baseline
Healthy men IR men IR women
Central 
tendency Dispersion
Central 
tendency Dispersion
Central 
tendency Dispersion
Age (years) 49* 8* 47 3 54* 6*
Body mass (kg) 83.6 8.8 96.3 12.6 84.5 10.4
BMI (kg/m2) 26.1 2.4 30.4 2.9 30.5 2.5
Whole body fat (%) 22.6 4.2 28.8 4.8 40.9 4.5
Abdominal SAT (kg) 4.2 1.4 6.3 2.4 9.33 2.13
Visceral fat (kg) 2.8 1.5 4.5 1.9 2.51 0.74
Cholesterol (mmol/L)* 5.00 0.90 4.70* 1.05* 5.07 0.55
HDL cholesterol (mmol/L) 1.29* 0.39* 1.23 0.29 1.50 0.35
LDL cholesterol (mmol/L) 3.14 0.80 2.71 0.82 2.96 0.60
Triglycerides (mmol/L) 0.99 0.31 1.60* 1.40* 1.34 0.50
f- FFA 0.70 0.19 0.68 0.17 0.97 0.12
HbA1c (mmol/mol) 36.9 3.8 39.6 5.6 39.5 2.4
HbA1c (%) 5.5 2.5 5.8 2.6 5.8 2.4
f- glucose (mmol/L) 5.47 0.40 6.95* 1.33* 6.80 0.59
f- insulin (mmol/L) 5.00* 2.50* 16.50* 11.00* 12.00* 5.01*
M- value (µmol/kg/min) 35.3 14.5 17.5 10.6 19.6 12.2
VO2peak (mL/kg/min) 34.2 4.1 29.3 3.7 23.8 3.9
For normally distributed parameters, measure of central tendency is expressed as arithmetic mean and dispersion as SD. For non- normally 
distributed parameters, measure of central tendency is expressed as median and dispersion as IQR (the difference between 75th and 25th 
percentiles).
*Non- normally distributed parameters.
BMI, body mass index; f- FFA, fasting free fatty acid; HbA1c, glycated hemoglobin; HDL, high- density lipoprotein; IR, insulin resistance; LDL, 
low- density lipoprotein; M- value, whole- body insulin sensitivity; SAT, subcutaneous adipose tissue; VO2peak, maximal aerobic capacity.
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according to the exercise mode, only SIT was associated 
with an increase in the VO2peak (SIT+5% vs MICT 0%, 
time*training p=0.047).
Femoral SAT glucose uptake improved with both 
SIT and MICT (25% and 20%, respectively, time 
p=0.004). However, in the VAT the training response 
was different between the two training modes with 
only SIT increasing VAT glucose uptake (30% vs 4%, 
time*training, p=0.03) and only MICT was associ-
ated with reduced VAT fatty acid uptake (−30% vs 
3%, p=0.01) (figure 5). Interestingly, the differential 
responses between the two training modes were still 
present when the VAT glucose uptake and fatty acid 
uptake were calculated per tissue depot (time*training, 
p=0.03 and p=0.007, respectively) (online supplemen-
tary figures 1 and 2). Additional descriptive statistics 
and results linear mixed model with repeated measures 
for characteristics of SIT and MICT training groups in 
all healthy and IR subjects, including both men and 
women, are presented in online supplementary table 4.
Of the studied genes, we found a significant decrease 
in CD36 and ANGPTL4 (p=0.042 and p=0.047, respec-
tively) after both training modes (figure 7). In addition, 
we saw an increase in adipose tissue vascularization after 
both training modes (figure 3B).
IR men versus IR women
IR women differed markedly from IR men, being older 
and having significantly higher whole- body fat content, 
abdominal SAT mass and plasma FFA concentration. 
However, they had significantly lower VAT mass when 
compared with IR men (online supplementary table 5).
At baseline, VAT glucose uptake and fatty acid uptake 
(19%, p=0.04 and 37%, p=0.002, respectively) and 
femoral SAT fatty acid uptake (18%, p=0.02) were signifi-
cantly higher in women compared with men (figure 6), 
Table 2 Descriptive statistics and results of hierarchical mixed linear models in characteristics of healthy and IR men
Healthy men IR men Baseline
Time
Time* 
IRPre Post Pre Post P value
n 28 26 16 13 – – –
Age (years) 48 – 49 – – – –
Body mass (kg) 83.6 (79.6 to 87.6) 83.3 (79.3 to 87.3) 96.3 (91.0 to 101.7) 96.1 (90.8 to 101.5) <0.001 0.22 0.78
BMI (kg/m2) 26.1 (25.1 to 27.1) 26.0 (25.0 to 27.0) 30.4 (29.1 to 31.8) 30.4 (29.0 to 31.8) <0.001 0.18 0.69
Whole- body fat 
(%)*
22.1 (20.5 to 23.9) 21.1 (19.5 to 22.7) 28.4 (25.6 to 31.5) 27.6 (24.9 to 30.7) <0.001 <0.001 0.30
Abdominal SAT 
(kg)
4.1 (3.5 to 4.7) 4.0 (3.4 to 4.6) 6.1 (5.18 to 7.18) 6.0 (5.1 to 7.1) <0.001 0.04 0.84
Visceral fat (kg)† 2.5 (2.0 to 3.2) 2.4 (1.9 to 3.08) 4.3 (5.4 to 3.4) 4.1 (3.1 to 5.1) 0.002 0.002 0.48
Cholesterol 
(mmol/L)*
4.92 (4.57 to 5.29) 4.40 (4.08 to 4.74) 4.71 (4.27 to 5.19) 4.31 (3.90 to 4.77) 0.44 <0.001 0.52
HDL cholesterol 
(mmol/L)*
1.37 (1.25 to 1.50) 1.27 (1.15 to 1.39) 1.20 (1.06 to 1.35) 1.09 (0.96 to 1.23) 0.08 <0.001 0.66
LDL cholesterol 
(mmol/L)
3.14 (2.85 to 3.43) 2.78 (2.48 to 3.08) 2.73 (2.34 to 3.12) 2.58 (2.18 to 2.98) 0.09 <0.001 0.16
Triglycerides 
(mmol/L)*
0.94 (0.81 to 1.11) 0.83 (0.70 to 0.98) 1.70 (1.38 to 2.10) 1.50 (1.19 to 1.90) <0.001 0.08 0.96
f- FFA 0.70 (0.62 to 0.77) 0.62 (0.54 to 0.69) 0.69 (0.60 to 0.78) 0.68 (0.59 to 0.78) 0.86 0.04 0.11
HbA1c (mmol/L) 36.93 (35.19 to 38.66) 34.72 (32.94 to 36.50) 39.64 (37.33 to 41.96) 37.65 (35.27 to 40.02) 0.07 <0.001 0.81
HbA1c (%) 5.5 (5.4 to 5.7) 5.3 (5.2 to 5.5) 5.8 (5.6 to 6.0) 5.6 (5.5 to 5.8) 0.07 0.001 0.8
f- glucose 
(mmol/L)*
5.44 (5.25 to 5.64) 5.74 (5.52 to 5.96) 7.20 (6.86 to 7.56) 7.16 (6.80 to 7.55) <0.001 0.15 0.80
f- insulin (mmol/L)* 4.70 (3.75 to 5.90) 5.85 (4.61 to 7.43) 14.49 (10.72 to 19.57) 13.58 (9.87 to 18.68) 0.001 0.37 0.10
M- value
(µmol/kg/min)
32.2 (26.6 to 39.0) 35.5 (29.2 to 43.2) 14.8 (11.4 to 19.2) 19.2 (14.7 to 25.19) <0.001 0.001 0.1
VO2peak
(mL/kg/min)
34.2 (32.7 to 35.7) 35.7 (34.2 to 35.7) 29.4 (27.3 to 31.5) 30.0 (27.9 to 32.1) <0.001 0.003 0.14
The p- value for “baseline” describes the baseline differences between the healthy (n=28) and IR (n=16) groups. “Time” shows all healthy and IR men 
after training. “Time*IR” demonstrates whether there is an interaction between the pre–post change and health status. All the data are presented as 
model- based means (95% CI). The values are model- based means and CIs translated into the original unit.
Bold values are statistically significant.
*Logarithmic transformation has been done to the variables to achieve the normal distribution.
†Square transformation to the variables to achieve the normal distribution.
BMI, body mass index; f- FFA, fasting free fatty acid; HbA1c, glycated hemoglobin; HDL, high- density lipoprotein; IR, insulin resistance; LDL, low- 
density lipoprotein; M- value, whole- body insulin sensitivity; SAT, subcutaneous adipose tissue; VO2peak, maximal aerobic capacity.
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but no significant baseline difference was found in 
abdominal SAT glucose uptake (figure 5). Training was 
associated with an increase in VAT glucose uptake both in 
men and women (21% and 8%, respectively, time p=0.04) 
and decreased VAT fatty acid uptake (−15% and −17%, 
respectively, time p=0.03) with no difference between 
the sexes. However, only men showed improvement in 
femoral SAT glucose uptake after exercise training (men 
37% vs women 7%, time*sex p=0.02).
DISCUSSION
The aim of the study was to investigate the effects of a 
2- week- long supervised, progressive exercise training on 
adipose tissue metabolism and morphology. The study 
demonstrates that short- term exercise training was asso-
ciated with an increase in insulin- stimulated VAT and 
femoral SAT glucose uptake and reduction in fasting 
VAT fatty acid uptake both in healthy participants and 
participants with IR. Interestingly, only SIT was associated 
with increased VAT glucose uptake, whereas only MICT 
decreased VAT fatty acid uptake in participants with IR. 
In addition, we observed an increase in adipose tissue 
vasculature and a decrease in abdominal SAT CD36 and 
ANGPTL4 mRNA expression in IR participants after both 
training modes. As expected,20 we found that women 
have metabolically more active adipose tissue than men 
with both higher glucose uptake and fatty acid uptake in 
VAT and femoral SAT.
Healthy versus IR (men)
In the present study, glucose uptake (µmol/min/100 g) 
was 29% lower in VAT, 32% lower in abdominal SAT and 
50% lower in femoral SAT in IR participants compared 
with healthy participants. However, when calculated per 
tissue depot, glucose uptake in these adipose tissues was 
similar between healthy and IR participants due to the 
significantly greater masses of these fat depots in the IR 
group as also shown previously.11
Exercise training induced significant improve-
ments in VAT and femoral SAT glucose uptake both in 
healthy (5% and 18%) and IR participants (21% and 
36%), respectively. Studies investigating the effects of 
training on adipose tissue insulin- stimulated glucose 
uptake in vivo in humans are scarce. Opposite to our 
findings, Reichkendler et al found a decrease in the 
Figure 3 Levels of different markers of (A) inflammation and (B) vascularization in plasma. Markers are visualized in three 
different comparisons: healthy versus insulin- resistant (IR) men, sprint interval training (SIT) versus moderate- intensity 
continuous training (MICT) in IR participants and men versus women in IR participants. All data are expressed as means and 
95% CIs. #p<0.05: difference at baseline. *p<0.05: the effect of exercise training over time in the whole group or a subgroup. 
Model- based means together with 95% CIs are presented. CRP, C reactive protein; TNF-α, tumor necrosis factor alpha; VEGF, 
vascular endothelial growth factor.
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insulin- stimulated abdominal SAT glucose uptake rate 
but no change in VAT or femoral SAT glucose uptake 
after 11 weeks of endurance training (>70% VO2max) in 
healthy sedentary moderately overweight men using 
PET and semiquantitative standard uptake modeling.34 
The authors suggested that insulin sensitivity does not 
increase in non- contracting adipose tissue, similar to 
those skeletal muscles that are not active during exer-
cise training. They also discussed about the possibility of 
contracting skeletal muscles signaling to adipose tissue 
to decrease glucose uptake to maintain the whole- body 
glucose homoeostasis. Interestingly, we found that when 
Figure 4 (A) Representative images of abdominal subcutaneous adipose tissue (SAT) stained with perilipin for adipocytes 
and CD31 for blood vessels. (B) Quantification of adipose tissue vasculature from CD31- stained sections. Values are shown 
in three different comparisons: healthy versus insulin- resistant (IR) men, sprint interval training (SIT) versus moderate- intensity 
continuous training (MICT) in IR participants and men versus women in IR participants. Data in the figure (B) are expressed as 
means and 95% CIs. *p<0.05, scale bar 100 mm. (C) Adipocyte cell size distribution from the total population of cells in SAT in 
healthy (A) and IR (B) participants before (white bars) and after (black bars) the intervention. Model- based means together with 
95% CIs are presented.
Figure 5 Insulin- stimulated glucose uptake (GU) per 100 g of tissue before (white bars) and after (black bars) the training 
intervention in visceral adipose tissue (VAT), abdominal subcutaneous adipose tissue (SAT) and femoral SAT. Glucose uptake 
is compared in three different comparisons: healthy versus insulin- resistant (IR) men (blue), sprint interval training (SIT) versus 
moderate- intensity continuous training (MICT) in IR participants (green) and men versus women in IR participants (red). All 
data are expressed as means and 95% CIs. #p<0.05: difference at baseline, ¤p<0.0: baseline difference after training, *p<0.05: 
the effect of exercise training over time in the whole group or a subgroup. Model- based means together with 95% CIs are 
presented.
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using femoral muscle glucose uptake35 as a covariant, the 
increase in femoral SAT glucose uptake was no longer 
significant. This suggests that the observed improvement 
in femoral SAT glucose uptake is due to the enhance-
ment of muscle glucose uptake facilitating the metabo-
lism of nearby tissues. We also tested the improvement 
in VAT glucose uptake by taking the glucose uptake of 
the nearby muscles as a covariate and found no change 
in the result. However, VAT is not very closely associated 
with nearby muscles, as these muscles are not working 
as much as the thigh muscles during exercise. VAT has 
also been shown to be distinct from other white adipose 
tissues with higher cellularity and greater glucose uptake 
per adipocyte which may explain the finding.36
In humans, SAT insulin- stimulated glucose uptake has 
been shown to be higher in vitro and in vivo in trained 
compared with sedentary participants using microdial-
ysis.37 38 Trained rats have also shown to have a greater 
relative amount of insulin- sensitive glucose transporters 
(GLUT4) as well as higher insulin- stimulated glucose 
transport in adipose tissue compared with sedentary 
animals.39–41 In the present study, we did not found 
Figure 6 Fasting free fatty acid uptake (FAU) per 100 g of the tissue before (white bars) and after (black bars) the training 
intervention in visceral adipose tissue (VAT), abdominal subcutaneous adipose tissue (SAT) and femoral SAT. Glucose uptake 
is compared in three different comparisons: healthy versus insulin- resistant (IR) men (blue), sprint interval training (SIT) versus 
moderate- intensity continuous training (MICT) in IR participants (green) and men versus women in IR participants (red). All data 
are expressed as means and 95% CIs. #p<0.05: difference at baseline. *p<0.05: the effect of exercise training over time in the 
whole group or a subgroup. Model- based means together with 95% CIs are presented.
Figure 7 Gene expression of CD36, ANGPTL4, CD68, GLUT4, FABP4 and FASN in abdominal subcutaneous adipose tissue. 
Genes are visualized in three different comparisons: healthy versus insulin- resistant (IR) men, sprint interval training (SIT) 
versus moderate- intensity continuous training (MICT) in IR participants and men versus women in IR participants. All data 
are expressed as means and 95% CIs. *p<0.05: the effect of exercise training over time in the whole group or a subgroup. 
ANGPTL4, angiopoietin- like 4; CD, cluster of differentiation; FABP4, fatty- acid binding protein 4; FASN, fatty acid synthase; 
GLUT4, glucose transporter type 4; PDK-4, pyruvate dehydrogenase lipoamide kinase isozyme 4; PPAR-γ, peroxisome 
proliferator- activated receptor gamma. Model- based means together with 95% CIs are presented.
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any change in abdominal SAT GLUT-4 protein mRNA 
expression.
It has been previously shown that FABP4 and CD36 
expression is upregulated in adipose tissue in participants 
with impaired insulin sensitivity and type 2 diabetes, asso-
ciated with increased fatty acid uptake, adipocyte hyper-
trophy and inflammation.42–45 A previous FTHA- PET 
study conducted in our laboratory showed more than 
100% higher fasting fatty acid uptake per 100 g in VAT, 
but not in abdominal SAT, in obese participants with a 
metabolic syndrome compared with lean participants.46 
In the present study, we did not observe significant differ-
ence in FABP4 or CD36 mRNA expression in abdominal 
SAT between IR and healthy participants. In addition, 
we observed lower fasting fatty acid uptake in VAT and 
abdominal SAT in IR compared with healthy participants. 
Interestingly, although the IR group in the present study 
had significantly higher body adiposity and impaired 
whole- body insulin sensitivity, we observed no difference 
in fasting plasma FFA between the groups. At baseline we 
also found no differences between the groups in genes 
regulating fatty acid uptake FABP4, CD36 and ANGPTL4. 
Thus, currently we do not have an explanation as to why 
the baseline fatty acid uptake uptake was lower in the IR 
compared with the healthy group.
After training, fatty acid uptake decreased in VAT 
and tended to decrease in abdominal and femoral SAT 
in both groups. In SAT biopsies, we found a trend indi-
cating a decreased expression of FABP4 in the IR but 
not in healthy participants (figure 7). In addition, when 
studying all IR participants, including women, both 
training modes led to a decrease in CD36 and ANGPTL4 
mRNA expression in abdominal SAT (figure 7). Our 
results with ANGPTL4 are in agreement with another 
study where the expression of ANGPTL4 was reduced 
after 12 weeks of exercise intervention.47 Although there 
is growing amount of evidence that ANGPTL4 is a key 
player in angiogenesis,48 the mechanism of reduction in 
ANGPTL4 expression in adipose tissue in association with 
exercise training stays unknown. The more pronounced 
effect of training on VAT fatty acid uptake compared 
with abdominal and femoral fatty acid uptake could be 
explained by the notion of VAT being metabolically more 
active and having a higher expression of β-adrenergic 
receptors compared with SAT, and thus when stimulated 
by exercise training this leads to a higher lipolysis.49
Previous studies have shown a relationship between 
SAT adipocyte cell size and IR both in VAT and SAT.50 51 
In addition, some studies have found an increased popu-
lation of small adipocytes (diameter 20–50 µm) in IR and 
type 2 diabetes.50 52 53 It has been suggested that in an IR 
state the maturation of adipocytes into functional cells is 
impaired, which results in the accumulation of ectopic 
fat.54 55 In the present study, we did not find a baseline 
difference between the healthy and IR groups as regards 
the average or median abdominal SAT adipocyte cell 
size. However, IR participants showed a trend toward 
an increased fraction of small cells compared with the 
healthy participants both at baseline and after the exer-
cise training (figure 4). After the training, we did not find 
a significant change in the mean or median adipocyte 
size in SAT, despite a small decrease in abdominal SAT 
mass. Thus, based on our present data and previous data 
collected by others,56 57 it seems that longer training inter-
ventions and more prominent weight loss are needed to 
induce changes in adipocyte cell size. Importantly, we 
observed an increased vasculature in abdominal SAT 
and decreased VEGF- A levels in plasma, which indicate 
a better perfusion not only in adipose tissue but also at 
the whole- body level. This is important, since hypoxia 
is an important driver of the adipose tissue inflamma-
tion observed in obesity and type 2 diabetes. It has been 
suggested that the crosstalk between adipocytes and 
vascularization is often lost during adipose tissue expan-
sion in obesity, leading to defective tissue perfusion, 
hypoxia and inflammation.58 59 Thus, our present find-
ings indicate that exercise training can promote adipose 
tissue vascularization and homeostasis.
SIT versus MICT (IR men and women)
Several recent studies have shown that high- intensity 
training can induce improvement in cardiometabolic 
health indices that are comparable or superior to tradi-
tional moderate- intensity training despite the significantly 
shorter time commitment.60 61 However, no previous 
studies have compared the exercise training- induced 
responses in adipose tissue metabolism and morphology 
after SIT and MICT in IR participants.
Both SIT and MICT led to similar improvements in 
whole- body adiposity, insulin sensitivity and femoral SAT 
glucose uptake. Importantly, both training modes were 
associated with decreased VAT mass and decreased total 
and LDL cholesterol, which are known risk factors for 
cardiometabolic diseases. It is already well recognized that 
the reduction in VAT mass even independent of weight 
loss is associated with reduced cardiovascular disease 
risk.62 We observed significant improvement in VAT 
glucose uptake only after SIT and VAT fatty acid uptake 
only after MICT. During exercise, glycogen and lipids are 
the primary substrates oxidized in the mitochondria to 
support muscle contraction. The energy used during the 
lower intensity training is produced mainly from lipids 
that are hydrolyzed from triglycerides via lipolysis.63 Fat 
oxidation typically falls as exercise intensity increases 
from moderate to heavy, after which carbohydrate oxida-
tion becomes primary source of the ATP.64 Therefore, 
during MICT, energy is mainly produced via fat oxida-
tion, and during SIT via fast glycogen stores, which may 
explain the different response in VAT fatty acid uptake 
after SIT and MICT.7
Women versus men
It is well recognized that the fat accumulation in different 
depots differs between men and women. Men accumu-
late more VAT, whereas women accumulate more SAT 
and have a higher percentage of body fat compared with 
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men.65 In the present study, the IR women had a 42% 
higher body fat content, a 51% higher abdominal SAT 
volume and a 45% lower VAT volume (online supple-
mentary table 2) than the IR men. The women also had 
a significantly higher VAT glucose uptake (figure 5), 
VAT fatty acid uptake and femoral SAT fatty acid uptake 
compared with men. Our results are in line with previous 
animal and human studies and demonstrate that despite 
the higher level of total body fat, women are more insulin 
sensitive than men.20 These findings may be related to 
sex steroids, which are known to play a role in the regu-
lation of adipose tissue development and function as well 
as whole- body insulin sensitivity, as it is considered that 
estrogen might have protective role against IR.20 Despite 
the significant baseline differences, the only difference 
between the males and females in the training response 
was observed in the femoral SAT glucose uptake, which 
only improved in men. This finding might be explained 
by higher muscle mass and pain tolerance in men, which 
allows men to push their limits further, especially during 
maximal effort in SIT training.
Limitations
The major limitation of our study is the relatively small 
number of participants, although it is in line with 
previous exercise training studies with similar technically 
and financially demanding and detailed designs. The 
statistical significance level was set to 0.05, indicating 
that there is a 5% risk of finding a false positive result 
for a given variable. Given the large number of tests 
performed with a rather small number of subjects, it is 
possible that some of the findings of this paper may be 
false positive. Therefore, the results should be consid-
ered as hypothesis- generating explorative analysis.
The participants were instructed to maintain their 
normal eating habits during the study, but nutrition 
was not controlled. Thus, it might be that some of the 
study participants increased their food intake as their 
energy expenditure increased and some may have eaten 
healthier during the intervention. This could have 
blunted the effect of intervention for some outcomes.
CONCLUSION
In conclusion, the present study demonstrated that a 2- week 
short- term supervised, progressive exercise training inter-
vention may improve adipose tissue metabolism both in 
healthy and IR participants independently of the sex. This 
study proposes that SIT improves VAT insulin- stimulated 
glucose uptake more efficiently than MICT, whereas MICT 
is preferable for VAT fatty acid uptake. Fatty acid uptake 
in adipose tissue and expression of FATB4, CD36 and 
ANGPTL4 mRNA decreases and adipose tissue vasculariza-
tion increases in IR participants with training.
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